The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The Discovery of Fluoxetine Hydrochloride (Prozac)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Gray, E. G., & Whittaker, V. P. (1962) · PubMed Central · Cited by 2,514
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735
Norepinephrine in Depressive Reactions: A Review
BUNNEY, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,153
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
Self-citationCarlsson, A., Corrodi, H., Fuxe, K., & Hökfelt, T. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90113-7 · Cited by 643
Serotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination
Twarog, B. M., & Page, I. H. (1953) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1953.175.1.157 · Cited by 532
Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
Shaskan, E. G., & Snyder, S. H. (1970) · PubMed · Cited by 517
Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., & Molloy, B. B. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90345-2 · Cited by 481
Self-citation5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
REGIONAL DIFFERENCES IN H3-NOREPINEPHRINE AND H3-DOPAMINE UPTAKE INTO RAT BRAIN HOMOGENATES
SNYDER, S. H., & COYLE, J. T. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28163-0 · Cited by 430
Carlsson, A., Fuxe, K., Hamberger, B., & Lindqvist, M. (1966) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1966.tb03334.x · Cited by 412
Carlsson, A., Corrodi, H., Fuxe, K., & Hökfelt, T. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90114-9 · Cited by 410
EFFECT OF DRUGS ON THE UPTAKE AND METABOLISM OF H3-NOREPINEPHRINE
HERTTING, G., AXELROD, J., & WHITBY, L. G. (1961) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26144-4 · Cited by 375
Wong, D. T., Bymaster, F. P., Horng, J. S., & Molloy, B. B. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30202-8 · Cited by 373
Self-citationPOTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHAN
Coppen, A., Shaw, D., & Farrell, J. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91084-5 · Cited by 344
Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue
Ross, S. B., & Renyi, A. L. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90091-0 · Cited by 319
Arias, E., Anderson, R. N., Kung, H.-C., Murphy, S. L., & Kochanek, K. D. (2003) · PubMed · Cited by 313
BOURNE, H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92459-8 · Cited by 304
Noradrenaline: Fate and Control of Its Biosynthesis
Axelrod, J. (1971) · Science · doi:10.1126/science.173.3997.598 · Cited by 292
The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?
Davidson, J. R. T., & Meltzer-Brody, S. E. (1999) · PubMed · Cited by 282
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Science · doi:10.1126/science.108.2804.329 · Cited by 276
Pare, C. M. B., Yeung, D. P. H., Price, K., & Stacey, R. S. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92442-8 · Cited by 262
LOW PREVALENCE OF HUNTINGTONS-DISEASE IN FINLAND
Palo, J., Somer, H., Ikonen, E., Karila, L., & Peltonen, L. (1900) · The Lancet · Cited by 253
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjoqvist, F. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973142277 · Cited by 242
Stark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239
Lumley, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90503-6 · Cited by 228
Lidbrink, P., Jonsson, G., & Fuxe, K. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90018-9 · Cited by 219
Perry, K. W., & Fuller, R. W. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90423-m · Cited by 217
Self-citationFuller, R. W., Perry, K. W., & Molloy, B. B. (1974) · Life Sciences · doi:10.1016/s0024-3205(74)80012-3 · Cited by 206
Self-citationAbrams, J. D., JAY, B. S., MELLERIO, J., & Weale, R. A. (1964) · PubMed · Cited by 201
Fluoxetine, a selective inhibitor of serotonin uptake
Fuller, R. W., Wong, D. T., & Robertson, D. W. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110103 · Cited by 198
Self-citationThe effect of imipramine of central 5-hydroxytryptamine neurons
Carlsson, A., Fuxe, K., & Ungerstedt, U. (1968) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1968.tb09706.x · Cited by 194
Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors
Wong, D. T., Bymaster, F. P., Reid, L. R., & Threlkeld, P. G. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90284-8 · Cited by 166
Self-citationPOTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN
Pare, C. M. B. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90271-x · Cited by 163
Prevalence and outcome of partial remission in depression
Tranter, R., O’Donovan, C., Chandarana, P. C., & Kennedy, S. H. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0242 · Cited by 162
Further Evidence That Serotonin Is a Neurotransmitter Involved in the Control of Prolactin Secretion
CLEMENS, J. A., SAWYER, B. D., & CERIMELE, B. (1977) · Endocrinology · doi:10.1210/endo-100-3-692 · Cited by 158
5-hydroxytryptamine uptake by rat brain
Blackburn, K. J., French, P. C., & Merrills, R. J. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90176-2 · Cited by 148
Fluoxetine tenth anniversary update: the progress continues
Stokes, P. E., & Holtz, A. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80066-5 · Cited by 140
Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices
Carlsson, A. (1970) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1970.tb08419.x · Cited by 139
Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.
Stevens, J. C., & Wrighton, S. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38409-0 · Cited by 138
Efficacy of newer medications for treating depression in primary care patients
Mulrow, C. D., Williams, J. W., Chiquette, E., Aguilar, C., Noël, P. H., Lee, S., Cornell, J. E., & Stamm, K. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00316-2 · Cited by 130
Localization of Indolealkylamines in CNS
Fuxé, K., Hökfelt, T. G. M., & Ungerstedt, U. (1968) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61177-1 · Cited by 123
Fluoxetine: a five-year review.
Stokes, P. E. (1993) · PubMed · Cited by 122
Wong, D. T., Horng, J.-S., & Fuller, R. W. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90412-7 · Cited by 118
Self-citationCarlsson, A., Jonason, J., Lindqvist, M., et al. (1969) · Brain Research · doi:10.1016/0006-8993(69)90013-4 · Cited by 115
Gillette, J. R., Dingell, J. V., Sulser, F., Kuntzman, R. G., & Brodie, B. B. (1961) · Cellular and Molecular Life Sciences · doi:10.1007/bf02157980 · Cited by 111
Wong, D. T., Horng, J. S., & Bymaster, F. P. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90531-7 · Cited by 84
Self-citationBeasley, C. M., Nilsson, M., Koke, S. C., & Gonzales, J. S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1003 · Cited by 62
RELIEF OF DEPRESSION WITHIN ONE DAY USING AN M.A.O. INHIBITOR AND INTRAVENOUS 5-HTP
Kline, N. S., & Sacks, W. (1963) · American Journal of Psychiatry · doi:10.1176/ajp.120.3.274 · Cited by 58
Safety and side effect profile of fluoxetine
Wernicke, J. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.495 · Cited by 56
Development of Antidepressant Drugs
Wong, D. T., & Bymaster, F. P. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1857-0_11 · Cited by 52
Self-citationThe Biochemistry of functional and experimental psychoses
(1973) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(73)90030-5 · Cited by 38
The Biochemistry of Functional and Experimental Psychoses
Goodwin, D. W. (1972) · JAMA · doi:10.1001/jama.1972.03190330071032 · Cited by 35
Cited by
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Albert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2010) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 316
Metadata
- Authors
- Wong, D. T., Perry, K. W., & Bymaster, F. P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-08-24
- Volume
- 4
- Issue
- 9
- Pages
- 764-774
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1598371539
- Cited by
- 418
- References
- 55
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.